L1 Capital reports 1.79% GeoVax Labs stake
L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 547,715 GeoVax Labs common stock equivalents as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 547,715 GeoVax Labs common stock equivalents as of 12/31/2025. These relate to warrants to purchase common stock acquired in July, September, and December 2025 private transactions.
The position represents 1.79% of GeoVax’s common stock class, based on 30,058,786 shares outstanding from a Form S-1. L1 Capital has sole voting and dispositive power over all 547,715 shares and certifies the holdings are not for the purpose of changing or influencing control of GeoVax.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in GeoVax Labs (GOVX) does L1 Capital report?
What type of securities does L1 Capital hold in GeoVax Labs (GOVX)?
How is L1 Capital’s 1.79% GeoVax (GOVX) ownership percentage calculated?
Does L1 Capital control voting and disposition of its GeoVax (GOVX) holdings?
Is L1 Capital’s GeoVax (GOVX) filing a passive investment certification?
Who are the individuals associated with L1 Capital’s GeoVax (GOVX) position?
AI-generated analysis. How Rhea-AI works. Not financial advice.